BRIEF-Paladin Labs enters agreement with QRxPharma for acute pain product

Oct 9 (Reuters) - Paladin Labs Inc :

* Announces agreement with QRxPharma for novel acute pain product

* Says under the terms of this agreement, Paladin will pay $500,000 upfront

* Paladin will also provide a series of milestone payments that can total up to

$25 million

* Says further financial details related to the agreement were not disclosed

* Source text* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))